GYRE THERAPEUTICS, INC. (GYRE) — Net Income

Annual figures by fiscal year, from SEC filings.

2009: -$39.40M2010: $10.90M2011: -$8.53M2012: -$7.00M2013: -$9.97M2014: -$6.61M2015: -$14.76M2016: -$16.95M2017: -$21.56M2018: -$30.05M2019: -$55.18M2020: -$56.24M2021: -$87.93M2022: $4.31M2023: -$85.48M2024: $17.90M2025: $9.88M$9.88M
2009Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025$9.88M-44.8%
2024$17.90M+120.9%
2023-$85.48M-2081.5%
2022$4.31M+104.9%
2021-$87.93M-56.4%
2020-$56.24M-1.9%
2019-$55.18M-83.6%
2018-$30.05M-39.4%
2017-$21.56M-27.2%
2016-$16.95M-14.8%
2015-$14.76M-123.2%
2014-$6.61M+33.6%
2013-$9.97M-42.4%
2012-$7.00M+18.0%
2011-$8.53M-178.3%
2010$10.90M+127.7%
2009-$39.40M